Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Improving skin barrier and using antifungal treatments can help manage dandruff.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Hair restoration surgery can potentially treat primary scarring alopecias, but it's important to start early medication, ensure patient remission before transplant, and monitor after surgery.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Vitiligo causes white skin patches and can lead to psychological stress.

The study found that white hair in vitiligo has specific patterns and structures, which vary with the stage of the disease and may be similar to another hair condition.

The man was diagnosed with lupus and improved with treatment.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

New research is helping develop better treatments for alopecia areata.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.